Weight gain and body mass index (BMI) increase are central issues in patients living with HIV who need to minimize the risk of metabolic disease. Information collected through the SCOLTA cohort revealed significant 1-year BMI increase in patients treated with dolutegravir (P = .004), raltegravir (P = .0004), elvitegravir (P = .004), darunavir (P = .0006), and rilpivirine (P = .029). BMI gain correlated with low baseline BMI (P = .002) and older age (P = .0007) in Centers for Disease Control and Prevention stages A/B, with lower BMI (P = .005) and CD4+ T-cell count (P = .007) at enrollment in stage C.

Taramasso, L., Ricci, E., Menzaghi, B., Orofino, G., Passerini, S., Madeddu, G., et al. (2017). Weight gain: A possible side effect of all antiretrovirals. OPEN FORUM INFECTIOUS DISEASES, 4(4), 1-3 [10.1093/ofid/ofx239].

Weight gain: A possible side effect of all antiretrovirals

Squillace N.;Bonfanti P.;
2017

Abstract

Weight gain and body mass index (BMI) increase are central issues in patients living with HIV who need to minimize the risk of metabolic disease. Information collected through the SCOLTA cohort revealed significant 1-year BMI increase in patients treated with dolutegravir (P = .004), raltegravir (P = .0004), elvitegravir (P = .004), darunavir (P = .0006), and rilpivirine (P = .029). BMI gain correlated with low baseline BMI (P = .002) and older age (P = .0007) in Centers for Disease Control and Prevention stages A/B, with lower BMI (P = .005) and CD4+ T-cell count (P = .007) at enrollment in stage C.
No
Articolo in rivista - Articolo scientifico
Scientifica
ART; BMI; Cardiovascular risk; Darunavir; INSTI; Rilpivirine; Weight
English
1
3
3
Taramasso, L., Ricci, E., Menzaghi, B., Orofino, G., Passerini, S., Madeddu, G., et al. (2017). Weight gain: A possible side effect of all antiretrovirals. OPEN FORUM INFECTIOUS DISEASES, 4(4), 1-3 [10.1093/ofid/ofx239].
Taramasso, L; Ricci, E; Menzaghi, B; Orofino, G; Passerini, S; Madeddu, G; Martinelli, C; De Socio, G; Squillace, N; Rusconi, S; Bonfanti, P; Biagio, A; Quirino, T; Bellacosa, C; Maggi, P; Calza, L; Abeli, C; Celesia, B; Grosso, C; Stagno, A; Vichi, F; Mazzotta, F; Penco, G; Cassola, G; Taramasso, L; Nicolini, L; Dentone, C; Molteni, C; Palvarini, L; Scalzini, A; Carenzi, L; Rizzardini, G; Valsecchi, L; Cordier, L; Colombo, V; Galli, M; Franzetti, M; Mazzotta, E; Parruti, G; Bagella, P; Mura, M; Libertone, R; Antinori, A; Di Giambenedetto, S; Guastavigna, M
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/276571
Citazioni
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 61
Social impact